ANDA 84220, held by Nexgen Pharma Inc. Meprobamate.
As of Nov 14, 2026, ANDA 84220 (Meprobamate), held by Nexgen Pharma Inc, was first approved by FDA on Sep 30, 1974, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 30, 1974 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Meprobamate200MG ยท tablet;oral | Meprobamate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
